Ruxolitinib Discontinuation Syndrome in a Patient With Myelofibrosis to Acute Myeloid Leukemia Transformation

JCO Oncol Pract. 2020 Jul;16(7):395-396. doi: 10.1200/JOP.19.00179. Epub 2019 May 18.
No abstract available

MeSH terms

  • Humans
  • Leukemia, Myeloid, Acute* / complications
  • Leukemia, Myeloid, Acute* / drug therapy
  • Nitriles
  • Primary Myelofibrosis* / complications
  • Primary Myelofibrosis* / drug therapy
  • Pyrazoles / adverse effects
  • Pyrimidines

Substances

  • Nitriles
  • Pyrazoles
  • Pyrimidines
  • ruxolitinib